li>Support maintaining of productive relationships with relevant specialty external stakeholders, including the Association of Community Cancer Centers (ACCC), the American Society of Clinical Oncology (ASCO), the Community Oncology Alliance (COA), the National Comprehensive Cancer Network (NCCN), as well as various specialty pharmacies, group purchasing organizations, pathways companies, payers and other stakeholders necessary to understand customer needs, anticipate shifts in market conditions, and help to shape the debate in emerging specialty polity issues. - Develop, maintain, and effectively communicate a thorough understanding of the complex and rapidly evolving factors influencing reimbursement/patient access to products in the US specialty market (including personalized medicine/molecular diagnostics, reimbursement trends, payer concerns, provider business issues, dispensing physicians, 340B hospitals, accountable care organizations, pathway initiatives, patient co-pay and coinsurance concerns, compedia policies/guidelines, and private and public policy issues) to lead development of reimbursement and access strategies for BI specialty products.